NCT05695716View on ClinicalTrials.gov

CSI Percutaneous Ventricular Assist Device (pVAD) Second in Human Study

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

April 5, 2023

Primary Completion Date

July 17, 2023

Study Completion Date

July 17, 2023

Conditions
Coronary Artery Disease
Interventions
DEVICE

CSI pVAD System

The CSI percutaneous ventricular assist device (pVAD) is being investigated as a temporary left ventricular system intended to support and/or provide hemodynamic stability during high-risk percutaneous coronary interventions.

Trial Locations (1)

Unknown

Tbilisi Heart & Vascular, Tbilisi

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY

NCT05695716 - CSI Percutaneous Ventricular Assist Device (pVAD) Second in Human Study | Biotech Hunter | Biotech Hunter